Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$46.84 - $59.75 $290,173 - $370,151
-6,195 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$48.09 - $57.79 $171,488 - $206,079
-3,566 Reduced 36.53%
6,195 $351,000
Q4 2021

Feb 10, 2022

BUY
$47.19 - $62.68 $460,621 - $611,819
9,761 New
9,761 $512,000
Q1 2019

May 10, 2019

SELL
$44.53 - $58.9 $382,022 - $505,303
-8,579 Closed
0 $0
Q4 2018

Feb 08, 2019

BUY
$47.64 - $71.26 $408,703 - $611,339
8,579 New
8,579 $471,000
Q3 2018

Nov 08, 2018

SELL
$52.03 - $71.41 $303,490 - $416,534
-5,833 Closed
0 $0
Q2 2018

Jul 13, 2018

BUY
$48.15 - $56.68 $280,858 - $330,614
5,833 New
5,833 $304,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.